Zomedica Corp. (NYSEAMERICAN:ZOM – Free Report) – Stock analysts at Noble Financial issued their FY2024 earnings per share estimates for shares of Zomedica in a research note issued to investors on Monday, November 11th. Noble Financial analyst R. Leboyer forecasts that the company will post earnings of ($0.05) per share for the year. Noble Financial has a “Strong-Buy” rating on the stock. The consensus estimate for Zomedica’s current full-year earnings is ($0.05) per share. Noble Financial also issued estimates for Zomedica’s Q4 2024 earnings at ($0.01) EPS, Q1 2025 earnings at ($0.01) EPS, Q2 2025 earnings at ($0.01) EPS, Q3 2025 earnings at ($0.01) EPS, Q4 2025 earnings at ($0.01) EPS, FY2025 earnings at ($0.03) EPS, FY2026 earnings at ($0.03) EPS and FY2027 earnings at ($0.03) EPS.
Zomedica Stock Performance
ZOM opened at $0.14 on Thursday. The company has a market cap of $132.29 million, a PE ratio of -2.29 and a beta of 1.06. Zomedica has a 52-week low of $0.12 and a 52-week high of $0.23.
Institutional Investors Weigh In On Zomedica
About Zomedica
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.
See Also
- Five stocks we like better than Zomedica
- When to Sell a Stock for Profit or Loss
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Upcoming IPO Stock Lockup Period, Explained
- Top-Performing Non-Leveraged ETFs This Year
- How to Invest in Small Cap StocksĀ
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Zomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zomedica and related companies with MarketBeat.com's FREE daily email newsletter.